Sphera Funds Management Ltd. Passage Bio, Inc. Transaction History

Sphera Funds Management Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$14.28 - $29.73 $3.8 Million - $7.91 Million	-266,037 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$12.39 - $26.15 $971,400 - $2.05 Million	-78,402 Reduced 22.76%	266,037 $3.49 Million
Q2 2020 Aug 13, 2020	SELL	$14.59 - $36.07 $1.95 Million - $4.82 Million	-133,732 Reduced 27.97%	344,439 $9.41 Million
Q1 2020 May 14, 2020	BUY	$8.86 - $22.2 $4.24 Million - $10.6 Million	478,171 New	478,171 $7.14 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.